U.S. Markets open in 2 hrs 12 mins

FibroGen reports 4Q loss

SAN FRANCISCO (AP) _ FibroGen Inc. (FGEN) on Wednesday reported a loss of $34 million in its fourth quarter.

On a per-share basis, the San Francisco-based company said it had a loss of 54 cents.

The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 65 cents per share.

The biotech drug developer posted revenue of $31.9 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $19.3 million.

For the year, the company reported that its loss narrowed to $61.7 million, or 98 cents per share. Revenue was reported as $179.6 million.

FibroGen shares have climbed 20 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $25.65, an increase of 42 percent in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FGEN at https://www.zacks.com/ap/FGEN


Keywords: FibroGen, Earnings Report